Skip to main content
. 2021 Feb 1;6(5):3548–3570. doi: 10.1021/acsomega.0c04763

Figure 4.

Figure 4

Reported biological and pharmacological activities of EGCG demonstrated in a series of clinical and preclinical studies and their implications in ameliorating the gastric pathologies caused by H. pylori.